An advisory panel to the US Food and Drug Administration on Thursday voted to recommend a booster shot of for many Americans, at least six months after their second dose.
The panel unanimously voted yes on a half-dose shot for people 65 and older, people 18 and older at high risk of severe COVID-19, and people 18 and older whose jobs put them at risk of COVID-19 infection. These are thelast month.
The COVID-19 vaccines are highly effective in preventing hospitalization and death. Over the summer, as the delta variant took hold in the US, the number of cases, hospitalizations and deaths from COVID-19 surged. Those who are unvaccinated have accounted for — over 97% as of July.
While the US already is offering a just 2.5% of people living in low-income countries have received at least one vaccine dose.to some people,
The vote by the FDA panel isn’t binding, but the agency will likely accept the recommendation. The FDAless than a week after an advisory panel made its recommendation.
The FDA already gave emergency authorization for a third dose of the Moderna vaccine for some adults who are immunocompromised.
The panel is meeting again Friday to discuss a booster dose for the Johnson & Johnson COVID-19 vaccine.